Obermoser V - Search Results

1

Fluorination as tool to improve bioanalytical sensitivity and COX-2-selective antitumor activity of cobalt alkyne complexes.

Baecker D, Obermoser V, Kirchner EA, Hupfauf A, Kircher B, Gust R. Baecker D, et al. Among authors: obermoser v. Dalton Trans. 2019 Nov 14;48(42):15856-15868. doi: 10.1039/c9dt03330k. Epub 2019 Oct 16. Dalton Trans. 2019. PMID: 31617517

2

Chlorinated cobalt alkyne complexes derived from acetylsalicylic acid as new specific antitumor agents.

Obermoser V, Baecker D, Schuster C, Braun V, Kircher B, Gust R. Obermoser V, et al. Dalton Trans. 2018 Mar 28;47(12):4341-4351. doi: 10.1039/c7dt04790h. Epub 2018 Mar 1. Dalton Trans. 2018. PMID: 29492489

3

Synthesis and Biological Evaluation of Zeise's Salt Derivatives with Acetylsalicylic Acid Substructure.

Weninger A, Baecker D, Obermoser V, Egger D, Wurst K, Gust R. Weninger A, et al. Among authors: obermoser v. Int J Mol Sci. 2018 May 30;19(6):1612. doi: 10.3390/ijms19061612. Int J Mol Sci. 2018. PMID: 29848978 Free PMC article.

4

New telmisartan-derived PPARγ agonists: Impact of the 3D-binding mode on the pharmacological profile.

Obermoser V, Urban ME, Murgueitio MS, Wolber G, Kintscher U, Gust R. Obermoser V, et al. Eur J Med Chem. 2016 Nov 29;124:138-152. doi: 10.1016/j.ejmech.2016.08.027. Epub 2016 Aug 15. Eur J Med Chem. 2016. PMID: 27569195

5

Importance of 5/6-aryl substitution on the pharmacological profile of 4'-((2-propyl-1H-benzo[d]imidazol-1-yl)methyl)-[1,1'-biphenyl]-2-carboxylic acid derived PPARγ agonists.

Obermoser V, Mauersberger R, Schuster D, Czifersky M, Lipova M, Siegl M, Kintscher U, Gust R. Obermoser V, et al. Eur J Med Chem. 2017 Jan 27;126:590-603. doi: 10.1016/j.ejmech.2016.11.051. Epub 2016 Nov 25. Eur J Med Chem. 2017. PMID: 27918994

6

Evaluation of selected 3D virtual screening tools for the prospective identification of peroxisome proliferator-activated receptor (PPAR) γ partial agonists.

Kaserer T, Obermoser V, Weninger A, Gust R, Schuster D. Kaserer T, et al. Among authors: obermoser v. Eur J Med Chem. 2016 Nov 29;124:49-62. doi: 10.1016/j.ejmech.2016.07.072. Epub 2016 Aug 6. Eur J Med Chem. 2016. PMID: 27560282 Free article.

7

Development of Zeise's Salt Derivatives Bearing Substituted Acetylsalicylic Acid Substructures as Cytotoxic COX Inhibitors.

Weninger A, Sagasser J, Obermoser V, Egger J, Wisboeck S, Qiu Q, Ladstaetter M, Cucchiaro A, Wurst K, Baecker D, Gust R. Weninger A, et al. Among authors: obermoser v. Pharmaceutics. 2023 May 23;15(6):1573. doi: 10.3390/pharmaceutics15061573. Pharmaceutics. 2023. PMID: 37376023 Free PMC article.

8

COPD Assessment Test Changes from Baseline Correlate with COPD Exacerbations: A Longitudinal Analysis of the DACCORD Observational Study.

Kardos P, Vogelmeier CF, Worth H, Buhl R, Obermoser V, Criée CP. Kardos P, et al. Among authors: obermoser v. Lung. 2020 Jun;198(3):507-514. doi: 10.1007/s00408-020-00357-y. Epub 2020 May 4. Lung. 2020. PMID: 32367415 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters